3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
4
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
3
NET
1
Gastrointestinal
1
Conditions
Neuroendocrine Tumors
46
Neoplasms
8
Carcinoid Tumor
7
Neoplasm Metastasis
5
Gastro-enteropancreatic neuroendocrine tumor
5
Pancreatic Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Gastrointestinal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Neuroendocrine
3
Adenoma, Islet Cell
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Serotonin Syndrome
2
Sarcoma
2
Pheochromocytoma
2
Paraganglioma
2
Neuroblastoma
2
Neoplasms by Site
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Cholangiocarcinoma
2
Carcinoma, Islet Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Adrenal Gland Neoplasms
2
von Hippel-Lindau Disease
1
Vipoma
1
Interventions
lanreotide
1
Octreotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Acromegaly
×
NET
×
Clear all
NCT05364944
2025-11-17
OXTEND-01
Debiopharm International SA
Phase 1
Terminated
19 enrolled